FDA issues flu vaccine recommendations
The recommendations were made in a closed session with representatives from CBER, the CDC and Department of Defense.
The U.S. FDA issues flu vaccine strain recommendations for 2025-2026 on its own without advisory input. Read more here.
The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.
Sanofi (SNY) announced the immediate adoption of influenza strains selected by the Food and Drug Administration to advance the manufacturing ...
News-Medical.Net on MSN5d
Updates on influenza vaccine strain recommended by WHO (2025-2026 northern hemisphere)To maintain vaccine efficacy, WHO regularly updates influenza vaccine strains based on global epidemiological, virological, ...
Vaccine hesitancy was rising even before COVID-19 emerged – but the pandemic exacerbated the trend. More kindergartners are ...
Scientists Design Workaround That Improves Response to Flu Vaccine Dec. 19, 2024 — Stitching together four molecules found in the standard flu vaccine ensures an immune response to all of them ...
The agency formulated its advice to manufacturers after coordinating with the CDC and Defense Department. An advisory meeting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback